Skip to content
VMAT Radiation Therapy - Volumetric Modulated Arc Therapy
Radiation Oncology

VMAT Radiation Therapy - Volumetric Modulated Arc Therapy

About This Department

 
Radiation Oncology

The beam stays on while the machine circles you, reshaping itself every few degrees. A full fraction is delivered in 1.5 to 3 minutes.

Those timings come from the 2008 paper in Medical Physics that introduced volumetric modulated arc therapy. Where the dose lands matters more than the speed. The arcs wrap radiation tightly around the tumor and bend it away from the salivary glands, the bowel, the bladder or the spinal cord, and randomized trials of intensity-modulated treatment have shown what that does for side effects. Send us your pathology report and staging scans, and a radiation oncologist will reply with the number of sessions, the weeks to plan for and what to expect.

1.5 to 3 min
Beam time for one VMAT fraction
38% vs 74%
Lasting dry mouth, intensity-modulated against conventional
20 sessions
Modern prostate course, down from 37
Free
Radiation oncologist's review of your file
Free consultation

What is VMAT radiation therapy?

Volumetric modulated arc therapy, VMAT, is a way of delivering external radiotherapy in which the treatment machine rotates around the patient in one or two continuous arcs with the beam switched on throughout. Three things change at once during the rotation, namely the shape of the beam, the speed of the machine and the rate at which dose is given. A computer plan sets all three for every few degrees of the arc.

The multileaf collimator sets the shape. It consists of thin tungsten leaves that slide in and out of the beam. At each angle the leaves form an outline that matches how the tumor looks from that direction while shielding whatever sensitive organ lies in front of or behind it. Added together over 360 degrees, hundreds of these shaped beams build a block of high dose that follows the contours of the target, curves included, and falls away steeply at its edges.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Three generations of external radiotherapy
  3D conformal Static-field IMRT VMAT
How the beam is delivered Three to six fixed beams, each with one fixed shape Five to nine fixed beams, each with a changing shape One or two rotating arcs, shape changing continuously
How well dose follows the tumor Box-like. Organs inside the box get the full dose Sculpted, including concave shapes Sculpted to the same standard as IMRT, sometimes better
Beam time per session A few minutes Ten to twenty minutes 1.5 to 3 minutes in the founding paper
Why the time matters   Patients and organs drift during a long session Less movement, less time in a mask, room for imaging before every fraction

VMAT belongs to the IMRT family. Nobody has shown that arcs cure more cancers than fixed modulated beams, and a 2011 review in the British Journal of Radiology said frankly that most of the published work compared treatment plans on a computer and not outcomes in patients. What the arc adds is speed, with dose distributions that Karl Otto's original paper described as equivalent or superior to static IMRT. The clinical proof that sculpted dose spares patients comes from the IMRT trials. Two stand out.

PARSPORT randomized 94 patients with throat cancer at six UK centers to conventional radiotherapy or to IMRT planned to spare the parotid salivary glands. A year later, 74 percent of the conventional group had a dry mouth of grade 2 or worse, against 38 percent of the IMRT group, and at two years the gap had widened to 83 against 29 percent. Tumor control did not differ. Nor did survival. Fatigue during treatment was more common with IMRT, which the trial reported openly, in The Lancet Oncology in 2011.

Prostate cancer supplied the second trial. Brazilian investigators randomized 215 men to the same dose given by IMRT or by 3D conformal treatment. Late bowel side effects of grade 2 or worse occurred in 6.4 percent with IMRT and 21.7 percent without, late bladder effects in 3.7 against 12.3 percent, and five-year control of the cancer was the same, 95.4 and 94.3 percent. The study appeared in the journal Cancer in 2016.

Same cure rate, fewer lasting side effects. The whole case for modulated radiotherapy fits in that line.

Which cancers is VMAT used for?

Wherever a tumor sits close to an organ that tolerates radiation badly, which covers the sites below, taken from the British Journal of Radiology review.

Prostate
The target lies between the bladder and the rectum, and both move from day to day. VMAT with daily imaging is the standard way of giving the modern four-week course.
Head and neck
Tumors of the throat, mouth, larynx, nose and sinuses sit among the salivary glands, the swallowing muscles, the spinal cord, the optic nerves and the brainstem. These plans are the most complex in radiotherapy and gain the most from modulation. A thermoplastic mask holds the head still.
Brain
Gliomas, meningiomas and metastases, sparing the hippocampus, the optic pathway and the brainstem where the target allows.
Lung and esophagus
Dose is shaped around the heart, the healthy lung and the spinal cord, and breathing motion is measured at planning and built into the target.
Pelvis
Cervical, uterine, rectal, anal and bladder cancers, often together with weekly chemotherapy, where modulation lowers the dose to small bowel and bone marrow. Cervical cancer also needs internal radiotherapy, brachytherapy, at the end of the course.
Breast
Used selectively, for left-sided cancers near the heart, for treatment of the lymph node chains, and for unusual chest shapes. Many breast treatments are planned well with simpler techniques.
Relief of symptoms
Painful bone deposits, spinal cord compression and bleeding tumors are treated in one to ten sessions. Simple techniques are enough for most of these, and arcs are used when the area has been irradiated before.

What happens between the first message and the last session?

  1. Remote review. Send the pathology report, the staging scans with their images, operation notes, any chemotherapy plan, and a summary of any earlier radiotherapy. A radiation oncologist replies with the intent of treatment, the number of fractions and the calendar.
  2. Consultation and consent. In person, with an interpreter. Examination, review of the images, discussion at the tumor board where surgery or chemotherapy is part of the plan.
  3. Simulation. A planning CT scan in the exact treatment position. A mask is molded for head and neck or brain treatment, a vacuum cushion for the body. Small marks or tattoo dots record the alignment. Prostate patients follow a bladder and bowel routine from this day on. MRI or PET images are fused with the CT where they show the tumor better.
  4. Contouring and planning. The oncologist outlines the target and every organ at risk on each CT slice, and a medical physicist builds the arc plan to meet dose limits for each one. This takes five to ten working days. It is the step that decides the quality of the whole course, and nobody sees it.
  5. Quality assurance. Before you are treated, the plan is delivered to a measuring device and the measured dose is compared with the calculated one.
  6. Treatment. One session a day, Monday to Friday. A weekly clinic visit with the oncologist and the nurse.
  7. Last day. A treatment summary with doses to the target and to each organ, a skin and symptom plan for the following weeks, and a follow-up schedule for your doctor at home.
Tell us before planning starts
Radiotherapy to the same region in the past, however long ago, with the records if you can get them. A pacemaker or implanted defibrillator. Pregnancy or any chance of it. Scleroderma, lupus or another connective tissue disease. Metal implants near the target. Difficulty lying flat or still for fifteen minutes, and fear of enclosed spaces if a mask will be needed.

Side effects, by the area treated

Radiotherapy affects only the part of the body it passes through, so the side effects of a brain treatment and a pelvic treatment have nothing in common. Tiredness makes the exception. It builds through the course, peaks a week or two after the last session and lifts over the following month. Early effects begin in the second or third week and settle within weeks of finishing.

Head and neck
Sore mouth and throat, thick saliva, loss of taste, skin redness, difficulty swallowing that can call for a feeding tube for some weeks. Dry mouth is the main lasting effect, and the one that parotid-sparing plans reduce.
Chest
Soreness on swallowing from the third week, a dry cough, and in a minority an inflammation of the lung one to six months later that is treated with steroids.
Pelvis
Frequent, hurried or burning urination, loose stools, rectal irritation. Lasting bowel and bladder changes occurred in 6 and 4 percent with IMRT in the prostate trial above, and effects on erections, fertility and, in women, the vagina and ovaries are discussed before consent.
Brain
Hair loss over the treated area, headache, nausea, and tiredness that can be marked. Steroids control swelling.
Breast and skin
Redness like sunburn, peeling in skin folds late in the course, lasting firmness or darkening in some women.

Report these the same day

  • Fever of 38 degrees or more, above all if you are also having chemotherapy.
  • Being unable to swallow fluids, or passing very little urine.
  • New weakness or numbness in the legs, or loss of bladder or bowel control.
  • Bleeding that does not stop, severe headache with vomiting, or a seizure.
Late effects
Changes that appear months or years afterward depend on the organ and the dose it received, and the dose limits used in planning exist to keep them rare. A second cancer caused by radiation is a recognized and very small risk that matters most for young patients. The oncologist states the late risks for your plan at consent, with numbers where trials provide them.

How many weeks will I need in Istanbul?

Add one to two weeks of preparation to the length of the course. Courses keep getting shorter. The CHHiP trial, published in The Lancet Oncology in 2016, randomized 3,216 men with prostate cancer at 71 centers to 37 sessions over seven and a half weeks or to 20 sessions over four. Five years on, the cancer was controlled in 90.6 percent of the 20-session group and 88.3 percent of the 37-session group. Side effects were alike. The shorter course became the recommended standard.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Usual international schedules
Cancer Sessions Weeks of treatment Notes
Prostate 20 4 Selected patients are treated in 5 stereotactic sessions.
Breast, after surgery 15, or 5 3, or 1 A boost to the tumor bed adds up to a week for some.
Head and neck 30 to 35 6 to 7 Weekly chemotherapy for many. Allow two weeks after the end for the reaction to peak and begin to settle before flying far.
Lung, curative 30 to 33 6 to 6.5 Early small tumors may have 3 to 8 stereotactic sessions.
Brain, glioma 30 6 With daily chemotherapy tablets.
Cervix, rectum, anus, bladder 25 to 28 5 to 5.5 Cervical cancer adds brachytherapy.
Relief of symptoms 1 to 10 1 day to 2 weeks Planned and started within days.

The table shows schedules in common use. The oncologist sets yours after the tumor board, and the reply to your first message will state it.

Arrive
Change, follow any bladder or bowel routine, and check in with the radiographers. Allow 30 to 45 minutes door to door.
Position
You lie on the couch in your mask or cushion, and lasers are lined up with your marks. The staff leave the room and watch and hear you throughout.
Image
A cone-beam CT, taken by the treatment machine itself, is matched to the planning scan, and the couch is shifted by millimeters to correct the day's position.
Treat
The machine makes its arcs. You feel nothing, see nothing and hear a hum. You are not radioactive afterward, and you can hold a child or sit beside a pregnant woman that evening.

Which machine is used?

The linear accelerator at Biruni Hospital is an Elekta Versa HD, a platform built for arc delivery. Its collimator has 160 leaves, each casting a five-millimeter shadow at the patient, it can run without a flattening filter to give dose at a higher rate for short-course treatments, and it carries the cone-beam CT used before each session. The hospital does not operate a CyberKnife or a Gamma Knife. If a dedicated radiosurgery platform would serve you better, the reply to your file will say so.

Brand names dominate the advertising of radiotherapy abroad, and they matter less than three things patients never see, the care taken over contouring, the time a physicist spends on the plan and its quality assurance, and whether imaging is done before every session or once a week. Ask about all three.

What decides the cost?

Hospitals quote radiotherapy by the course, and they price the course by its number of sessions and the complexity of its plan. A one-session palliative treatment and a 35-session head and neck course with two dose levels differ by an order of magnitude in physics time alone. Planning images add to the bill when MRI or PET-CT has to be repeated for fusion. Each mask and cushion serves one patient. Daily image guidance, plan checks and any re-planning when weight loss or tumor shrinkage changes the anatomy are part of a well-run course, and a quote should say whether they are included. Then come the extras. Weekly chemotherapy, blood tests, a feeding tube, dental work before head and neck treatment, and hormone injections for prostate cancer sit outside the radiotherapy price. So does the hotel. Over a six-week course, accommodation and meals for two people make up a large share of what the family spends, a point that short modern schedules such as the 20-session prostate course and the five-session breast course have changed for travelers more than any advance in the machines. Age, diabetes, heart disease and earlier treatment to the same area all add consultations and checks.

Packages published by hospitals in Istanbul are sold by session bands, such as 1 to 14, 20 to 25 or 30 to 33 sessions, and list the consultation, planning, an interpreter and transfers, with hotel nights in some. Compare them on four points, the technique named in writing, the imaging schedule, what happens if a re-plan is needed, and whether the treatment summary with organ doses is provided in English.

Your own figure follows the free review of your file.

What about living in Istanbul for weeks, and care once I am home?

A course of radiotherapy means living in the city, and the arrangements reflect that. One coordinator from the international patients team is assigned from your first message and stays with you to the last session. The team works in English, Arabic, French, Russian, Serbian, Romanian and Spanish and arranges interpreting in other languages on request. An invitation letter naming the hospital and the treating doctor is sent about ten days before travel, so check how many days your visa allows. Six weeks of treatment can outlast a tourist stamp. The international patients office arranges the airport transfer, an apartment or hotel for you and a companion, and the daily ride, and an apartment with a kitchen suits most families better than a hotel after the second week. Surgery, chemotherapy and radiotherapy are on one site, so combined treatment needs no travel between hospitals. Rooms for patients admitted during treatment have a companion bed. Halal, vegetarian and diabetic meals come from the hospital kitchen, a prayer room is on site, and a request for a female doctor is passed to the department and met wherever the rota allows.

You can fly safely at any point, including between sessions on a weekend.

Back home, your coordinator stays reachable on the same WhatsApp number. The first follow-up visit falls four to six weeks after the last session, and your own oncologist can do it with the treatment summary in hand, since that document records every dose a future doctor will need. Keep it for life. Any radiotherapy you are offered later, for this cancer or another, in this country or any other, will be planned around the doses written in it.

VMAT FAQ

Is VMAT better than IMRT?
VMAT is a form of IMRT delivered in rotating arcs. The dose distribution is equivalent or slightly better, and the session is much shorter, 1.5 to 3 minutes of beam time in the original report. No trial has shown a difference in cure rates between the two.
Does VMAT hurt?
No. You feel nothing during the session. Side effects come on gradually from the second or third week and depend on the area treated.
How long is each session?
The beam is on for a few minutes. With positioning and imaging, plan on 10 to 15 minutes in the room and 30 to 45 minutes at the hospital.
How many weeks do I need to stay?
The length of your course plus one to two weeks for consultation, simulation and planning. That means five to six weeks for a 20-session prostate course and eight to nine for head and neck treatment.
Will I be radioactive?
No. External radiotherapy leaves no radiation in the body. You can be with children and pregnant women straight after each session.
Can my family stay with me?
Yes. The international patients office arranges an apartment or hotel for you and a companion for the whole course, and rooms for admitted patients have a companion bed.

References

  1. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Medical Physics. 2008;35(1):310-317.
  2. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. British Journal of Radiology. 2011;84(1007):967-996.
  3. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncology. 2011;12(2):127-136.
  4. Viani GA, Viana BS, Martin JE, Rossi BT, Zuliani G, Stefano EJ. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial. Cancer. 2016;122(13):2004-2011.
  5. Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncology. 2016;17(8):1047-1060.

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Metin GÜDEN, Radiation Oncology.

Related Treatments

View All